ProtaGene is a leading global provider of advanced analytical services for biopharmaceutical, cell, and gene therapy developers. With expertise spanning from early research through commercial product release, ProtaGene offers comprehensive solutions in biologic drug analytics, molecular bioanalysis, and cell and gene therapy characterization. Their state-of-the-art technologies support critical decision-making across the entire product development lifecycle, ensuring safety, efficacy, and regulatory compliance. ProtaGene’s integrated approach accelerates development timelines and enhances the success of therapeutic programs worldwide.
Visit Company Website
